Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Histopathological characteristics of hypervascular cholangiocellular carcinoma as an early stage of cholangiocellular carcinoma.

Sato Y, Ojima H, Onaya H, Mori T, Hiraoka N, Kishi Y, Nara S, Esaki M, Shimada K, Kosuge T, Sugihara K, Kanai Y.

Hepatol Res. 2014 Oct;44(11):1119-29. doi: 10.1111/hepr.12236. Epub 2014 Jan 7.

PMID:
24033892
[PubMed]
2.

Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.

Tang D, Nagano H, Yamamoto H, Wada H, Nakamura M, Kondo M, Ota H, Yoshioka S, Kato H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Wakasa K, Monden M.

Oncol Rep. 2006 Mar;15(3):525-32.

PMID:
16465407
[PubMed - indexed for MEDLINE]
3.

An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.

Haratake J, Hashimoto H.

Liver. 1995 Feb;15(1):9-15.

PMID:
7539881
[PubMed - indexed for MEDLINE]
4.

Expression of Fas and Fas ligand reflects the biological characteristics but not the status of apoptosis of intrahepatic cholangiocellular carcinoma.

Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Matsuura N.

Int J Mol Med. 2000 Nov;6(5):581-6.

PMID:
11029528
[PubMed - indexed for MEDLINE]
5.

Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.

DeLair D, Oliva E, Köbel M, Macias A, Gilks CB, Soslow RA.

Am J Surg Pathol. 2011 Jan;35(1):36-44. doi: 10.1097/PAS.0b013e3181ff400e.

PMID:
21164285
[PubMed - indexed for MEDLINE]
6.

Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.

Herrmann G.

Z Gastroenterol. 1999 May;37(5):329-42.

PMID:
10413841
[PubMed - indexed for MEDLINE]
7.

Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.

Benckert C, Jonas S, Cramer T, Von Marschall Z, Schäfer G, Peters M, Wagner K, Radke C, Wiedenmann B, Neuhaus P, Höcker M, Rosewicz S.

Cancer Res. 2003 Mar 1;63(5):1083-92.

PMID:
12615726
[PubMed - indexed for MEDLINE]
Free Article
8.

[An immunohistochemical study on primary carcinoma of the liver].

Seo JK.

J UOEH. 1989 Dec 1;11(4):429-39. Japanese.

PMID:
2481871
[PubMed - indexed for MEDLINE]
9.

Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.

Kawahara N, Ono M, Taguchi K, Okamoto M, Shimada M, Takenaka K, Hayashi K, Mosher DF, Sugimachi K, Tsuneyoshi M, Kuwano M.

Hepatology. 1998 Dec;28(6):1512-7.

PMID:
9828214
[PubMed - indexed for MEDLINE]
10.

Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.

Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC, Zhou X, Ding YT.

World J Gastroenterol. 2012 Sep 21;18(35):4925-33.

PMID:
23002366
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Pathogenetic role of HBV in liver cell carcinoma of Western European patients].

Herrmann G, Gregel C, Hübner K.

Verh Dtsch Ges Pathol. 1995;79:126-31. German.

PMID:
8600676
[PubMed - indexed for MEDLINE]
12.

Clinicopathologic study on cholangiolocellular carcinoma.

Shiota K, Taguchi J, Nakashima O, Nakashima M, Kojiro M.

Oncol Rep. 2001 Mar-Apr;8(2):263-8.

PMID:
11182037
[PubMed - indexed for MEDLINE]
13.

Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases.

Chen MF, Jan YY, Chen TC.

Ann Surg. 1998 Jan;227(1):63-9.

PMID:
9445112
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].

Pozharisskiĭ KM, Granov DA, Ten VP, Kubaĭbergenova AG, Leenman EE, Rasskazov AI.

Vopr Onkol. 2008;54(4):417-33. Russian.

PMID:
18942395
[PubMed - indexed for MEDLINE]
15.

Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma.

Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Matsuura N.

Oncology. 2001;60(3):242-51.

PMID:
11340376
[PubMed - indexed for MEDLINE]
16.

Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.

Padden J, Megger DA, Bracht T, Reis H, Ahrens M, Kohl M, Eisenacher M, Schlaak JF, Canbay AE, Weber F, Hoffmann AC, Kuhlmann K, Meyer HE, Baba HA, Sitek B.

Mol Cell Proteomics. 2014 Oct;13(10):2661-72. doi: 10.1074/mcp.M113.034942. Epub 2014 Jul 17.

PMID:
25034945
[PubMed - in process]
Free PMC Article
17.
18.

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.

Kloeckner R, Ruckes C, Kronfeld K, Wörns MA, Weinmann A, Galle PR, Lang H, Otto G, Eichhorn W, Schreckenberger M, Dueber C, Pitton MB.

Trials. 2014 Aug 6;15:311. doi: 10.1186/1745-6215-15-311.

PMID:
25095718
[PubMed - in process]
Free PMC Article
19.

Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma.

Saito S, Tsuno N, Nagawa H, Sunami E, Zhengxi J, Osada T, Kitayama J, Shibata Y, Tsuruo T, Muto T.

Cancer. 2000 Jan 1;88(1):42-9.

PMID:
10618604
[PubMed - indexed for MEDLINE]
20.

Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.

Fujii T, Zen Y, Harada K, Niwa H, Masuda S, Kaizaki Y, Watanabe K, Kawashima A, Nakanuma Y.

Hum Pathol. 2008 Aug;39(8):1185-96. doi: 10.1016/j.humpath.2007.12.010. Epub 2008 Jun 10.

PMID:
18547618
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk